Calcium folinate tablets

This product is a formyl derivative of tetrahydrofolate. It is mainly used to rescue high-dose methotrexate and other folic acid antagonists. The main function of methotrexate is to bind to dihydrofolate reductase, blocking the conversion of dihydrofolate to tetrahydrofolate, thereby inhibiting DNA synthesis. After entering the human body, this product is converted into tetrahydrofolate by tetrahydrofolate reductase, which can effectively counteract the toxic reaction caused by methotrexate.

Keep away from light and store in sealed container.

This product is off-white to yellow tablets.

1. Mainly used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim, etc.). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment of methotrexate. 3. Megaloblastic anemia caused by folic acid deficiency. 4. When used in combination with fluorouracil, it is used to treat advanced colon cancer and rectal cancer.

1. As a "rescue" therapy for methotrexate, the commonly used dose is 5-15 mg (1/3 to 1 tablet), taken orally every 6-8 hours for 2 consecutive days. The blood concentration of methotrexate is controlled below 5×10-8 mol/L according to the results of blood concentration determination. 2. As a detoxification of pyrimethamine or trimethoprim, the daily oral dose is 5-15 mg (1/3 to 1 tablet), depending on the poisoning situation. 3. For megaloblastic anemia, take 15 mg (1 tablet) orally daily. 4. When used in combination with fluorouracil, take 20-30 mg/m2 of body surface area orally half an hour before taking fluorouracil.

Rarely, allergic reactions such as rash, hives, or asthma may occur occasionally.

It is contraindicated in pernicious anemia or megaloblastic anemia caused by vitamin B12 deficiency.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

The use of this product in large doses together with barbiturates, primidone or phenytoin sodium may affect the anti-epileptic effect.

Keep away from light and store in sealed container.

15 mg (as folinic acid)

24 months

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

• Founded in:

  1997-04-28

• Address:

  No. 38 Huanghe Road, Lianyungang Economic and Technological Development Zone

• Tax NO.:

  9132070070404786XB

• Registered Funds:

  6,379,002,274 yuan

• Website:

  Log in to view

• Email:

  Log in to view